When Should Open-Label Extension Studies Be Stopped?

被引：0
|
作者：
Crites, Joshua S. [1 ]
机构：
[1] Penn State Coll Med, Hershey, PA 17033 USA
来源：
AMERICAN JOURNAL OF BIOETHICS | 2014年 / 14卷 / 04期
关键词：
CLINICAL-TRIALS;
D O I：
10.1080/15265161.2014.889957
中图分类号：
B82 [伦理学（道德学）];
学科分类号：
摘要：
引用
收藏
页码：57 / 58
页数：2
相关论文
共 50 条
  • [31] Final Data from Open-Label Extension Studies of Dalfampridine Extended Release Tablets in Multiple Sclerosis
    Goodman, Andrew
    Blight, Andrew
    NEUROLOGY, 2012, 78
  • [32] Long-term effects of troglitazone - Open-label extension studies in type 2 diabetic patients
    Fonseca, V
    Foyt, HL
    Shen, K
    Whitcomb, R
    DIABETES CARE, 2000, 23 (03) : 354 - 359
  • [33] AbobotulinumtoxinA (Dysport) dosing in cervical dystonia: an exploratory analysis of two large open-label extension studies
    Robert A. Hauser
    Daniel Truong
    Jean Hubble
    Chandra Coleman
    Jean-Luc Beffy
    Stephen Chang
    Philippe Picaut
    Journal of Neural Transmission, 2013, 120 : 299 - 307
  • [34] TRIFERIC MAINTAINS HEMOGLOBIN AND IRON BALANCE LONG TERM: OPEN-LABEL PHASE III EXTENSION STUDIES
    Pratt, Carrie Guss Raymond D.
    Lin, Vivian
    Gupta, Ajay
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 67 (05) : A50 - A50
  • [35] WHEN SHOULD ANTIEPILEPTIC DRUGS BE STOPPED
    LOISEAU, P
    NOUVELLE PRESSE MEDICALE, 1972, (01): : 47 - &
  • [36] WHEN SHOULD UVEITIS TREATMENT BE STOPPED
    BLOCHMICHEL, E
    OFFRET, M
    CHHOR, S
    OFFRET, H
    PATARIN, D
    OPHTHALMOLOGY TODAY, 1988, 803 : 123 - 124
  • [37] Sarilumab Dose Reduction in an Open-label Extension Study in RA Patients
    Genovese, Mark
    Fay, Jonathan
    Parrino, Janie
    Beyer, Doris
    Iglesias-Rodriguez, Melitza
    van Hoogstraten, Hubert
    Graham, Neil
    Boddy, Alex
    Simon, Abraham
    Martincova, Renata
    Burmester, Gerd
    Fiore, Stefano
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 895 - 896
  • [38] Interim analysis: Open-label extension study of leniolisib for patients with APDS
    Rao, V. Koneti
    Kulm, Elaine
    Sediva, Anna
    Plebani, Alessandro
    Schuetz, Catharina
    Shcherbina, Anna
    Dalm, Virgil A.
    Trizzino, Antonino
    Zharankova, Yulia
    Webster, Sharon
    Orpia, Alanvin
    Koeurorholz, Julia
    Lougaris, Vassilios
    Rodina, Yulia
    Radford, Kath
    Bradt, Jason
    Relan, Anurag
    Holland, Steven M.
    Lenardo, Michael J.
    Uzel, Gulbu
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (01) : 265 - 274.e9
  • [39] Results from an open-label extension study of etanercept in ankylosing spondylitis
    Davis, J
    Webb, A
    Lund, S
    Sack, K
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2004, 51 (02): : 302 - 304
  • [40] An open-label extension study of alendronate in elderly women with osteoporosis.
    Harris, ST
    Downs, R
    Bone, H
    Yates, AJ
    Lombardi, A
    Harning, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : S468 - S468
12345